North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 21 of 21
Details
UPD
sitematrix Changed from 0 to
20/11/2023 12:45:38
(DavidS )
UPD
FurtherInformation Changed from
Approved for gastrointestinal stromal tumours (GISTs) in line with NICE.
Approved for advanced and/or metastatic renal cell carcinoma in line with NICE.
Suni
20/11/2023 12:45:38
(DavidS )
UPD
Sunitinib (Sutent
®
) updated formatting
20/11/2023 12:45:38
(DavidS )
LDL
Link Added : MHRA Drug Safety Update (January 2011): Bevacizumab and sunitinib: risk of osteonecrosis of the jaw : https://www.gov.uk/drug-safety-update/bevacizumab-and-sunitinib-risk-of-osteonecrosis-of-the-jaw
14/07/2023 13:11:38
(dmcdermott )
LDL
Link Added : MHRA Drug Safety Update (July 2020): Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection : https://www.gov.uk/drug-safety-update/systemically-administered-vegf-pathway-inhibitors-risk-of-aneurysm-and-arte
11/07/2023 17:35:29
(dmcdermott )
UPD
sitematrix Changed from 0 to
11/07/2023 17:34:30
(dmcdermott )
UPD
Sunitinib (Sutent
®
) =
11/07/2023 17:34:30
(dmcdermott )
UPD
sitematrix Changed from 0 to
11/07/2023 17:29:28
(dmcdermott )
UPD
FurtherInformation Changed from
Approved for gastrointestinal stromal tumours (GISTs) in line with NICE.
Approved for advanced and/or metastatic renal cell carcinoma in line with NICE.
Su
11/07/2023 17:29:28
(dmcdermott )
UPD
Sunitinib =
11/07/2023 17:29:28
(dmcdermott )
UPD
sitematrix Changed from 0 to
17/12/2021 11:47:06
(LoweryM )
UPD
FurtherInformation Changed from
Approved for gastrointestinal stromal tumours (GISTs) in line with NICE.
Approved for advanced and/or metastatic renal cell carcinoma in line with NICE.
Sunitinib not a
17/12/2021 11:47:06
(LoweryM )
UPD
Sunitinib formatting
17/12/2021 11:47:06
(LoweryM )
UPD
Sunitinib updated
09/05/2018 11:43:36
(LoweryM )
UPD
Published from Draft Mode
27/10/2017 15:18:17
(DavidS )
LDL
Link Added : NICE TA449 Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease : https://www.nice.org.uk/guidance/ta449
26/10/2017 16:20:34
(DavidS )
UPD
Sunitinib NICE TA449
26/10/2017 16:20:03
(DavidS )
UPD
Sunitinib b
01/02/2017 15:27:55
(DavidS )
UPD
Sunitinib b
23/01/2017 15:21:22
(WhitehallJ )
UPD
Sunitinib 50mg, 100mg, and 400mg capsules b
23/01/2017 11:12:30
(WhitehallJ )
UPD
Sunitinib (Sutent
®
) build
28/11/2016 15:50:37
(DavidS )